IRIS
MARZIO, Leonardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.577
EU - Europa 5.605
AS - Asia 5.561
SA - Sud America 641
Continente sconosciuto - Info sul continente non disponibili 276
AF - Africa 70
OC - Oceania 9
Totale 20.739
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.417
SG - Singapore 2.033
CN - Cina 1.619
UA - Ucraina 977
IT - Italia 798
IE - Irlanda 782
TR - Turchia 702
SE - Svezia 642
RU - Federazione Russa 601
GB - Regno Unito 588
BR - Brasile 515
VN - Vietnam 459
FR - Francia 455
IN - India 421
DE - Germania 351
FI - Finlandia 209
CA - Canada 80
BD - Bangladesh 74
PL - Polonia 61
HK - Hong Kong 48
MX - Messico 41
AR - Argentina 38
IQ - Iraq 32
EC - Ecuador 31
KR - Corea 27
ID - Indonesia 23
ZA - Sudafrica 22
ES - Italia 20
JP - Giappone 19
CO - Colombia 18
BE - Belgio 17
EU - Europa 17
NL - Olanda 15
RO - Romania 15
CZ - Repubblica Ceca 13
PK - Pakistan 13
MA - Marocco 12
PY - Paraguay 12
LT - Lituania 11
AT - Austria 10
GR - Grecia 10
IL - Israele 10
UZ - Uzbekistan 10
AU - Australia 9
CL - Cile 9
JM - Giamaica 9
DZ - Algeria 8
KE - Kenya 8
SA - Arabia Saudita 8
EG - Egitto 7
JO - Giordania 7
AE - Emirati Arabi Uniti 6
PE - Perù 6
PH - Filippine 6
AL - Albania 5
AZ - Azerbaigian 5
IR - Iran 5
NI - Nicaragua 5
VE - Venezuela 5
CH - Svizzera 4
ET - Etiopia 4
GT - Guatemala 4
HN - Honduras 4
MY - Malesia 4
PS - Palestinian Territory 4
PT - Portogallo 4
BO - Bolivia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
GE - Georgia 3
MD - Moldavia 3
NO - Norvegia 3
NP - Nepal 3
OM - Oman 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
CI - Costa d'Avorio 2
HU - Ungheria 2
KZ - Kazakistan 2
LB - Libano 2
SC - Seychelles 2
SR - Suriname 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
UY - Uruguay 2
BB - Barbados 1
BH - Bahrain 1
BM - Bermuda 1
BY - Bielorussia 1
CG - Congo 1
CM - Camerun 1
CU - Cuba 1
DK - Danimarca 1
EE - Estonia 1
GD - Grenada 1
HR - Croazia 1
IM - Isola di Man 1
Totale 20.470
Salva come PNG Salva come JPEG
Città #
Singapore 1.351
Jacksonville 1.080
San Jose 804
Chandler 779
Dublin 768
Dearborn 458
Ashburn 426
Southend 422
Council Bluffs 407
Princeton 386
Dallas 353
Beijing 337
Izmir 333
Nanjing 327
Wilmington 258
Los Angeles 209
Cambridge 181
Ho Chi Minh City 159
Santa Clara 137
Tongling 135
New York 128
Buffalo 126
Woodbridge 118
Ann Arbor 113
The Dalles 110
Nanchang 104
Hanoi 96
Rome 66
Boardman 65
Houston 65
Moscow 64
Shenyang 62
Hebei 56
São Paulo 55
Altamura 54
Munich 50
Kunming 49
Hefei 48
Tianjin 46
Jiaxing 44
Hong Kong 38
Kraków 36
Redondo Beach 36
Chieti 35
Milan 34
Hangzhou 33
Phoenix 30
Da Nang 29
Bologna 28
Columbus 28
Brooklyn 26
Jinan 26
Norwalk 24
London 23
Grevenbroich 22
Guangzhou 22
Boston 21
Dong Ket 20
Orange 20
Toronto 20
Warsaw 20
Washington 20
Changsha 19
Guayaquil 19
Seoul 19
Haiphong 18
Helsinki 18
Orem 18
Tokyo 18
Chicago 17
Denver 17
Frankfurt am Main 17
Brussels 16
Montreal 16
Rio de Janeiro 16
Stockholm 16
Atlanta 15
Düsseldorf 15
San Francisco 15
Augusta 14
Belo Horizonte 14
Brasília 14
Chennai 14
Johannesburg 14
Seattle 14
Turku 14
Vinh 14
Charlotte 13
Pescara 13
Baghdad 12
Changchun 12
Lanzhou 12
Hải Dương 11
San Mateo 11
Ankara 10
Curitiba 10
Ningbo 10
Brno 9
Cepagatti 9
Fuzhou 9
Totale 11.962
Salva come PNG Salva come JPEG
Nome #
Il tempo di transito oro-cecale (TTOC) è accelerato dopo somministrazione orale di allergene alimentare nei pazienti con sindrome del colon irritabile (SCI) e prick test positivo 408
EFFICACY OF TREATMENT WITH PYLERA IN COMBINATION WITH RANITIDINE ON FIRST-LINE INFECTION HELICOBACTER PYLORI: EXPERIENCE OF A SINGLE CENTER 398
A Triple and Quadruple Therapy with Doxycycline and Bismuth for First-Line Treatment of Helicobacter pylori Infection: A Pilot Study 190
Pylera® plus ranitidine vs Pylera® plus esomeprazole in first-line treatment of Helicobacter pylori infection: Two pilot studies 180
48-Hour continuous pH measurement in patients with gastro-oesophageal reflux: effect of cisapride. 177
Beneficial effects of SR140333, a novel substance P antagonist, in a rat model of experimental colitis 176
Bovine lactoferrin enhances the efficacy of levofloxacin-based triple therapy as first-line treatment of Helicobacter pylori infection: an in vitro and in vivo study. 172
SYMPTOM PATTERN IN FUNCTIONAL DYSPEPSIA AND GASTROESOPHAGEAL REFLUX DISEASE: ROLE OF H. PYLORI INFECTION 172
Analysis of genetic variability, antimicrobial susceptibility and virulence markers in Helicobacter pylori identified in Central Italy. 169
Antibacterial effect of plant extracts against Helicobacter pylori 167
24-hour pancolonic motility using a portable electronic probe in healthy subjects 166
In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy 164
SR140333, a substance P receptor antagonist, influences morphological and motor changes in rat experimental colitis 161
Detection of Helicobacter pylori in the gastrointestinal tract of Balb/C euthymic mice infected by human Helicobacter pylori and evidence for transmission 157
Anti-H pylori specific antibody immunoistochemistry improves the diagnostic accuracy of H piylori in biopsy specimen from patients treated with triple therapy 156
Anti-Helicobacter pylori specific antibody immunohistochemistry improves the diagnostic accuracy of Helicobacter pylori in biopsy specimen from patients treated with triple therapy.Am. J. Gastroenterol 153
Coccoid Helicobacter pylori not culturable in vitro reverts in mice. 153
Anal canal diameters and pessure measured simultaneously by real time ultrasonography and manometry in human subjects 151
Two weeks regimen with amoxillicin, tinidazole and omeprazole eradicates helicobacter pylori and cures active duodenal ulcer 151
Aortic glutathione-related antioxidant defences in rabbits subjected to suprarenal aortic coarctation hypertension 150
Cigarette smoke, ferritin, and lipid peroxidation 148
Alterazioni contrattili della muscolatura liscia nel corso di colite sperimentale sono ridotte da un antagonista specifico della sostanza P 148
Correlation between anal canal size and anal canal pressure: an ultrasonografhip and manometric study 144
Circadian variations in antioxidant defences and lipid peroxidation in the rat heart 144
FUSOBACTERIUM NUCLEATUM (FN) IN PATIENTS AFFECTED BY INFLAMMATORY BOWEL DISEASE 143
Trasmissione di Helicobacter pylori in un modello murino 142
COMBINED VIDEOCAPSULE ENDOSCOPY (VCE) AND LACTULOSE HYDROGEN BREATH TEST (LHBT): A COMPARATIVE STUDY TO ASSESS ORO-CECAL TRANSIT TIME (OCTT). 142
Blood cardioplegia reduces oxidant burden in the ischemic and reperfused human myocardium 142
Diameters and pressures of the anal canal simultaneously measured with endosonography and manometry 138
Heightened free radical activity in angina pectoris 138
THE INFLUENCE OF ACID REFLUX ON THE HEART RATE VARIABILITY (HRV) IN PATIENTS WITH AND WITHOUT GASTROESOPHAGEAL REFLUX DISEASE (GERD) 138
EVALUATION OF INTRAPARENCHYMAL AND PORTAL BLOOD FLOW BY CONTRAST ENHANCED ULTRASOUND (CEUS) AND LIVER STIFFNESS BY FIBROSCAN IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CHRONIC HEPATITIS C (CHC) 138
THE INFLUENCE OF ACID REFLUX ON THE HEART RATE VARIABILITY (HRV) IN PATIENTS WITH AND WITHOUT GASTROESOPHAGEAL REFLUX DISEASE (GERD). 138
Effect of ischemia and reperfusion on antioxidant enzymes and mitochondrial inner membrane proteins in perfused rat heart. 136
Helicobacter pylori isolates from proximal and distal stomach of patients never treated and already treated show genetic variability and discordant antibiotic resistance. 136
Gastric antral and fundus receptive relaxation in dyspeptic patients and normal subjects 135
EVALUATION OF INTRAPARENCHYMAL AND PORTAL BLOOD FLOW BY CONTRAST ENHANCED ULTRASOUND (CEUS) AND LIVER STIFFNESS BY FIBROSCAN IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CHRONIC HEPATITIS C (CHC). 135
PRUCALOPRIDE ACCELERATES GASTRIC AND SMALL BOWEL TRANSIT TIMES OF VIDEOCAPSULES ENDOSCOPY 135
Morphological and motor changes during experimental colits in rats are prevented by a specific substance p antagonist 134
Detection of Helicobacter pylori in saliva and esophagus 133
Uso razionale di schemi terapeutici nelle infezioni da Helicobacter pylori 133
ESOPHAGITIS AND ITS CAUSES: WHO IS "GUILTY" WHEN ACID IS FOUND "NOT GUILTY"? 133
L'eritromicina accelera lo svuotamento gastrico e colecistico nell'uomo attraverso un meccanismo mediato dall'acetilcolina 132
[Physiopathological bases of the medical treatment of portal hypertension]. 131
Prolonged anal sphincter manometry in normal human subjects 130
H2-RECEPTOR ANTAGONISTS ARE SCAVENGERS OF OXYGEN RADICALS 130
Pharyngeal, Esophageal and Gastric Motility in Normal Subjects and in patients with gastroesophageal Reflux Disease 129
Short- and long-term omeplazole for the tratment and prevention of duodenal ulcer, and effect on helicobacter pylori 128
Role of antimicrobial susceptibility testing on efficacy of triple therapy in Helicobacter pylori eradication. 128
MIGRATING MOTOR COMPLEX RECORDED SPONTANEOUSLY AND INDUCED BY MOTILIN AND ERYTHROMYCIN IN AN EX VIVO RABBIT INTESTINAL PREPARATION 128
Rifabutin based triple therapy for eradication of H.pylori primary and secondary resistant to tinidazole and clarithromycin 127
Heparin: does it act as an antioxidant in vivo? 127
5-HT1-RECEPTOR AGONIST SUMATRIPTAN MODIFIES GASTRIC SIZE AFTER 500 ML OF WATER IN DYSPEPTIC PATIENTS AND NORMAL SUBJECTS 127
Treatment of Helicobacter pylori (Hp) infection with an association of Omeprazole and Roxytromicine: a study in vivo and in vitro. 126
Detection of Helicobacter pylori in esophagus and saliva in humans 125
Swallows, oesophageal and gastric motility in normal subjects and in patients with gastro-oesophageal reflux disease: a 24-h-pH-manometric study 124
Masse all'ipocondrio dx e carcinoma della colecisti 124
Effects of cimetropium bromide on gallbladder contraction in response to oral and intraduodenal olive oil. 124
Triple therapy for 7 days plus omeprazole for 21 days in treatment of active duodenal ulcer with Helicobacte pylori infection. A double blind placebo controlled trial. 123
Regional distribution of glutathione-related antioxidant defences in the normal rabbit aorta. 122
Glutathione peroxidase, glutathione reductase and glutathione transferase activities in the human artery, vein and heart. 122
Erythromycin accellerates gastric and gallbladder emptying through a cholinergic mediated mechanism in humans 122
Oesophageal and gastric motility in patients with gastro-oesophageal reflux disease 121
CAN HELICOBACTER PYLORI INFECTION HAVE A ROLE ON CLINICAL APPEARANCE OF GERD? 121
Effect of omeprazole, clarithromicin and amoxicillin for a short time on helicobacter pylori eradication 120
EVALUATION OF LIVER BLOOD FLOW AND FIBROSIS IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CIRRHOSIS IN COMPARISON WITH NORMAL CONTROLS THROUGH CONTRAST ENHANCED ULTRASOUND(CEUS) AND FIBROSCAN 120
Evidence for an oro-fecal transmission inan experimental murine model of helicobacter pylori infection. 119
TYPICAL AND ATYPICAL SYMPTOMS OF GASTRO ESOPHAGEAL REFLUX DISEASE: DOES Helicobacter pylori MATTER? 119
EFFECT OF CIMETROPIUM BROMIDE ON GALLBLADDER CONTRACTION IN RESPONSE TO ORAL AND INTRADUODENAL OLIVE OIL 117
PRUCALOPRIDE INCREASES BASAL LES TONE IN PATIENTS WITH ESOPHAGEAL MOTILITY DISORDERS 117
Esophageal and gastric motility in patients with gastroesophageal reflux disease 114
Role of transient lower esophageal sphincter relaxations in the genesis of priximal gastro-esophageal reflux 114
Effect of glyceryl trinitrate ointment (GTO) 0.2% and 2% on anal canal pressure during acute and chronic application in patients with anal fissure 114
ESOPHAGEAL MOTILITY ASSESSMENT AFTER PRUCALOPRIDE ADMINISTRATION IN PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY (IEM) AND SYSTEMIC SCLEROSIS. 114
Distensione gastrica nei soggetti normali e nei pazienti dispeptici helicobacter pylori positivi e negativi e correlazione con i sintomi 113
LA MALDIGESTIONE 113
Registrazione delle 24 ore della motilità del piloro in soggetti normali 112
Identification of a novel mutation affecting domain V of the 23S rRNA gene in Helicobacter pylori 112
TRANSIENT LOWER ESOPHAGEAL SPHINCTER RELAXATIONS AND GASTRO-ESOPHAGEAL REFLUX EPISODES IN HEALTHY SUBJECTS AND GERD PATIENTS DURING 24 HOURS 112
Changes in the myocardial enzymatic systems (AES) induced by ischemia-reperfusion in the isolated rat heart 112
I RILASCIAMENTI TRANSITORI DELLO SFINTERE ESOFAGEO INFERIORE NELLA GENESI DEI REFLUSSI GASTRO-ESOFAGEI: PROSPETTIVE TERAPEUTICHE 111
SHORT AND LONG TERM EFFICACY OF GLYCERYL TRINITRATE (GTN) OINTMENT 0.2% AND 2% ON ANAL CANAL PRESSURE IN PATIENTS WITH CHRONIC ANAL FISSURES. 111
La terapia chirurgica laparoscopica della malattia da reflusso gastro-esofageo 110
DISORDINI MOTORI ASPECIFICI DELL’ESOFAGO 110
EFFECT OF THE 5-HT3 RECEPTOR ANTAGONIST, ONDANSETRON, ON GASTRIC SIZE IN DYSPEPTIC PATIENTS WITH IMPAIRED GASTRIC ACCOMODATION 110
ULTRASOUND(US) GRADED HEPATOSTEATOSIS ASSESSMENT THROUGH CONTRAST ENHANCED ULTRASOUND (CEUS) AND FIBROSCAN IN NON ALCOHOLIC FATTY LIVER DISEASE 110
Effects of combining extracts (from Propolis or Zingiber officinale) with Clarithromycin on H.pylori. 109
EFFICACIA E SICUREZZA DEL RITRATTAMENTO CON INFLIXIMAB IN UN PAZIENTE AFFETTO DA MORBO DI CROHN 109
EFFECT OF AN ACUTE INTRALUMINAL ADMINISTRATION OF CAPSAICIN ON OESOPHAGEAL MOTOR PATTERN IN GORD PATIENTS WITH INEFFECTIVE OESOPHAGAL MOTILITY 108
Proximal and Distal Gastric Distension in Normal Subjects and H. pylori-Positive and -Negative Dyspeptic Patients and Correlation with Symptoms 107
Influence of physical activity on gastric emptying of liquids in normal human subjects 107
EFFECT OF CLEBOPRIDE ON ESOPHAGEAL MOTOR FUNCTION IN GERD PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY: EVALUATION USING HIGH RESOLUTION MANOMETRY 107
SPONTANEOUS OPENING OF LES IN ACHALASIA: AN UNCOMMON ON-LINE DOCUMENTATION BY HIGH-RESOLUTION MANOMETRY 107
EFFECT OF THE 5-HT1 AGONIST SUMATRIPTAN ON ESOPHAGEAL MOTOR PATTERN IN PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY 106
Gastric antral and fundic distention evaluated by ultrasonography (US) in normal subjects and patients with idiopathic dyspepsia 105
Relationship between interdigestive esophageal and gastric motility in humans 105
ROLE OF PRUCALOPRIDE (RESOLOR) IN THE SETTING-UP OF PILLCAM COLON-CAPSULE ENDOSCOPY (CCE). EXPERIENCEFROM A SINGLE CENTRE 105
EVALUATION OF INTRA PARENCHYMAL AND PORTAL BLOOD FLOW BY CONTRAST ENHANCED ULTRASOUND (CEUS) AND FIBROSIS BY FIBROSCAN IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NON ALCOHOLIC STEATOHEPATITIS (NASH) AND COMPARISON WITH NORMAL CONTROLS 105
Proximal and Distal Gastric Distension in Normal Subjects and H.pylori-Positive and -Negative Dyspeptic Patients and Correlation with Symptoms 104
Role of nitric oxide on peristaltic motor activity in an in vitro rabbit intestinal preparation 104
Totale 13.587
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.008
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.008
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022754 0 0 6 200 75 9 10 65 55 6 89 239
2022/20232.220 199 234 122 268 186 514 150 160 259 29 54 45
2023/20241.019 77 52 65 29 33 313 252 40 3 41 17 97
2024/20252.642 189 410 308 38 65 67 48 161 335 110 279 632
2025/20265.662 466 278 668 697 468 367 818 437 563 429 382 89
2026/2027683 220 347 116 0 0 0 0 0 0 0 0 0
Totale 20.739